Company research / BZYR

BURZYNSKI RESEARCH INSTITUTE INC (BZYR)

Build a valuation ↗↓ Download CSV

CIK 0000724445 · OTC · In Vitro & In Vivo Diagnostic Substances

Sector Manufacturing
Incorporated DE
Fiscal year ends Feb 28

For the year ended 2025-02-28, BURZYNSKI RESEARCH INSTITUTE INC reported revenue of $0.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-05-12

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-02-28	2024-02-29	2023-02-28	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28	2017-02-28	2016-02-29
Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Operating Income	-$1.39M	-$1.34M	-$916.3K	-$976.7K	-$1.30M	-$1.63M	-$1.64M	-$1.61M	-$1.50M	-$2.01M
Net Income	-$1.39M	-$1.34M	-$916.3K	—	—	—	—	—	—	—
EPS (Diluted)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	—	—	—	—	—
Total Assets	$847	$2.3K	$1.9K	$4.7K	$956	$19.9K	$22.2K	$28.9K	$10.7K	$4.0K
Total Liabilities	$42.5K	$27.4K	$15.7K	$3.5K	$46.8K	$172.4K	$208.8K	$136.6K	$43.7K	$105.0K
Shareholders' Equity	-$41.6K	-$25.1K	-$13.7K	$1.2K	-$45.8K	-$152.6K	-$186.6K	-$107.7K	-$33.0K	-$101.0K
Cash & Equivalents	$847	$1.3K	$934	$3.4K	$62	$163	$708	$506	$731	$3.3K
Operating Cash Flow	-$388.5K	-$523.8K	-$249.5K	-$325.1K	-$394.4K	-$530.1K	-$477.5K	-$319.5K	-$314.5K	—
Shares Outstanding	131.45M	131.45M	131.45M	131.45M	131.45M	131.45M	131.45M	131.45M	131.45M	131.45M
Weighted Average Diluted Shares	131.45M	131.45M	131.45M	131.45M	131.45M	—	—	—	—	—
EPS (Basic)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	—	—	—	—	—